PUBLISHER: The Business Research Company | PRODUCT CODE: 1946598
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946598
Neurorehabilitation devices are specialized tools that assist recovery in patients with neurological injuries or diseases, aiming to restore lost movement, function, and independence after conditions such as stroke or spinal cord injury.
The primary products in the neurorehabilitation devices market include brain-computer interfaces, wearable devices, non-invasive stimulators, and others. A brain-computer interface (BCI) is a technology that enables direct interaction between the brain and external devices, bypassing traditional neuromuscular pathways. These devices are used in applications such as stroke rehabilitation, Parkinson's disease management, brain and spinal cord injury treatment, cerebral palsy, multiple sclerosis, and others. The end users include rehabilitation centers, hospitals and clinics, home care environments, and others.
Tariffs are impacting the neurorehabilitation devices market by increasing costs of robotic components, sensors, and electronic modules, particularly impacting neurorobotics and wearable devices in North America and Europe. Rehabilitation centers face higher equipment costs. On the positive side, tariffs have supported domestic manufacturing and accelerated regional innovation ecosystems.
The neurorehabilitation devices market research report is one of a series of new reports from The Business Research Company that provides neurorehabilitation devices market statistics, including neurorehabilitation devices industry global market size, regional shares, competitors with a neurorehabilitation devices market share, detailed neurorehabilitation devices market segments, market trends and opportunities, and any further data you may need to thrive in the neurorehabilitation devices industry. This neurorehabilitation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The neurorehabilitation devices market size has grown rapidly in recent years. It will grow from $2.07 billion in 2025 to $2.32 billion in 2026 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to rising stroke incidence, growth in rehabilitation centers, increasing awareness of neurorehabilitation, advancements in assistive devices, expansion of physical therapy services.
The neurorehabilitation devices market size is expected to see rapid growth in the next few years. It will grow to $3.58 billion in 2030 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to aging population growth, demand for home care rehabilitation, technological innovation in exoskeletons, rising neurological injury cases, increased healthcare funding. Major trends in the forecast period include growing adoption of robotic rehabilitation systems, rising use of wearable neurorehabilitation devices, expansion of home-based rehabilitation programs, increased focus on personalized therapy plans, integration of cognitive and physical rehabilitation.
The increasing prevalence of neurological diseases is increasingly supporting the expansion of the neurorehabilitation devices market going forward. The growing number of neurological disease cases is influenced by factors such as aging populations, improved diagnostic capabilities, greater awareness, and rising stress and mental health concerns. Neurorehabilitation devices are used to support patients with neurological diseases by assisting in the recovery of motor, cognitive, and sensory functions through targeted therapies and stimulation techniques. For example, in May 2025, according to Headway, a UK-based non-profit organization, 335,409 people in the UK were admitted to hospitals during 2023-2024 due to acquired brain injury. As a result, the increasing prevalence of neurological diseases is strengthening demand for neurorehabilitation devices.
Leading companies operating in the neurorehabilitation devices market are focusing on developing innovative products, such as hyper-sensitive controllers, to enhance precision and patient engagement during rehabilitation therapy. A hyper-sensitive controller is designed to respond accurately to subtle user movements or neural signals. For example, in February 2023, MindMaze, a Switzerland-based digital neurotherapeutics company, launched Izar, a portable smart peripheral device that improves hand motor function in patients with neurological conditions including stroke and Parkinson's disease. The device detects fine grasp forces and wrist movements to enable precise training and assessment, supporting both in-clinic and remote rehabilitation.
In August 2023, ReWalk Robotics Ltd., an Israel-based medical device company, acquired AlterG for $19 million. This acquisition is intended to broaden ReWalk's product portfolio and strengthen its position in the rehabilitation and mobility market by combining AlterG's anti-gravity treadmill technology with its existing exoskeleton solutions. AlterG is a US-based provider of anti-gravity systems used in physical and neurological rehabilitation.
Major companies operating in the neurorehabilitation devices market are ReWalk Robotics Ltd., Ottobock SE & Co. KGaA, Helius Medical Technologies Inc., Bioness Inc., Neofect Co. Ltd., Tyromotion GmbH, Ekso Bionics Holdings Inc., Reha Technology AG, Kinestica Inc., Motus Nova, NeuroGym, NeuroMetrix Inc., Rehab-Robotics Company Limited, Rex Bionics Ltd., Saebo Inc., Bionik Laboratories Corp., Medtronic plc, Abbott Laboratories, Hocoma AG, Cyberdyne Inc., MindMaze SA, NeuroPace Inc., Paradromics Inc., Cognixion
North America was the largest region in the neurorehabilitation devices market in 2025. The regions covered in the neurorehabilitation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the neurorehabilitation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The neurorehabilitation devices market consists of sales of robotic exoskeletons, neuroprosthetics, brain-computer interfaces (BCI), functional electrical stimulation (FES) devices, transcranial magnetic stimulation (TMS) devices, virtual reality (VR), and rehabilitation systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Neurorehabilitation Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses neurorehabilitation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for neurorehabilitation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurorehabilitation devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.